Drug profile · INN
dordaviprone hydrochloride
MODEYSO
dordaviprone hydrochloride (MODEYSO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Drug details — dordaviprone hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 5
- Data quality
- 0.84
Quick answer
dordaviprone hydrochloride (MODEYSO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is dordaviprone hydrochloride?
dordaviprone hydrochloride (MODEYSO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for dordaviprone hydrochloride?
MODEYSO is a marketed brand name for dordaviprone hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dordaviprone hydrochloride?
dordaviprone hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.